- Report
- June 2026
- 200 Pages
Global
From €2675EUR$2,990USD£2,292GBP
- Report
- May 2026
- 150 Pages
Global
From €5323EUR$5,950USD£4,560GBP
- Report
- January 2026
- 199 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- January 2026
Global
From €4383EUR$4,900USD£3,756GBP
- Report
- January 2026
Global
From €4383EUR$4,900USD£3,756GBP
- Report
- September 2026
- 187 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 197 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 198 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 198 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 195 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 374 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 274 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 473 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 395 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 386 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 384 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 383 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 506 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 363 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,441GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more